About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Breast Cancer Clinical Trials in California | 1,848 Studies

Clinical Trials Breast CancerCalifornia

Breast Cancer Clinical Trials in California

Find 1,848 clinical trials for breast cancer near California. Connect with research centers in your area.

All Breast Cancer trials nationwide All trials in California

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1521-1540 of 1,848 trials

CompletedA Study of Abemaciclib (LY2835219) in Participants With Breast Cancer, Non-small Cell Lung Cancer, or Melanoma That Has Spread to the BrainThe main purpose of this study is to evaluate the safety and effectiveness of the study drug known as abemaciclib in participants with hormone receptor positive breast cancer…NCT02308020·Duarte, California and 43 others

Breast Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedStudy of Ductal Lavage in Women at High Risk for Breast CancerRATIONALE: Collecting samples of fluid using ductal lavage and nipple aspiration from participants at high risk for breast cancer to study in the laboratory may help doctors learn…NCT00429988·San Francisco, California

UnknownBreast Cancer Biomarker Sample Collection for the dtectDx v2 Assay Proof of Concept ProtocolThe major purpose of this study is to evaluate a laboratory developed test that measures multiple breast cancer-specific biomarker proteins and multiple antibodies in your blood…NCT02078570·Phoenix, Arizona and 11 others

RecruitingTrastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast CancerThis phase II trial investigates how well trastuzumab deruxtecan works alone or in combination with anastrozole in treating patients with HER2 low, hormone receptor positive…NCT04553770·Fullerton, California and 8 others

UnknownIntraoperative Boost Radiotherapy With Electrons (IOERT) Followed By Hypofractionated Whole-Breast Irradiation (WBRT)Hypofractionated intraoperative boost (HIOB) is defined as hypofractionated WBRT (40.5 Gy in 2.7 Gy per fraction) preceded by an intraoperative boost to the tumor bed (10 Gy…NCT01295723·Orange, California

CompletedCognitive Rehabilitation Group Intervention for Breast Cancer SurvivorsThere are over 2 million breast cancer survivors in the US today.NCT01540955·Los Angeles, California

TerminatedA Study Evaluating The PF-03084014 In Combination With Docetaxel In Patients With Advanced Breast CancerThis study is aimed to determine the tolerability of the PF-03084014 plus docetaxel combination in patients with advanced breast cancer.NCT01876251·Birmingham, Alabama and 15 others

TerminatedTesting the Use of Fulvestrant and Binimetinib Targeted Treatment for NF1 Mutation in Hormone Receptor-Positive Metastatic Breast Cancer (A ComboMATCH Treatment Trial)This phase II ComboMATCH treatment trial compares the usual treatment alone (fulvestrant) to using binimetinib plus the usual treatment in patients with hormone receptor positive…NCT05554354·Birmingham, Alabama and 195 others

RecruitingNovel Body Composition Measurements in Association With Outcomes of Breast Reconstruction ReconstructionThis study compares measurements of body composition to outcomes of breast reconstruction.NCT07546331·San Francisco, California

CompletedGW572016 and Trastuzumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER2/NeuRATIONALE: GW572016 may stop the growth of tumor cells by blocking the enzymes necessary for their growth.NCT00085020·Los Angeles, California

CompletedA PK Study Testing Single Oral Dose of Elacestrant in Subjects With Normal or Severely Impaired Hepatic FunctionThis is a Phase 1, multi-center, open-label, non-randomized, parallel group study to evaluate the effect of severe hepatic impairment on the PK, safety and tolerability of a…NCT06126575·Yucaipa, California and 2 others

RecruitingStudy of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.This is a multicenter randomized, open label study to evaluate overall survival with the Bria-IMT regimen in combination with Checkpoint Inhibitor \[Retifanlimab\], versus…NCT06072612·Phoenix, Arizona and 78 others

RecruitingA Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid TumorsThis is a first-in-human, Phase 1/2 study to evaluate LCB84, a TROP2-directed antibody-drug conjugate, alone and in combination with an anti-PD-1 Ab, in dose escalation (Phase 1)…NCT05941507·Los Angeles, California and 7 others

CompletedPatient Controlled Tissue Expansion for Breast ReconstructionThis study is designed to compare the performance and safety of the AirXpander tissue expander to standard saline expanders in patients undergoing two-stage breast reconstruction…NCT01425268·Greenbrae, California and 16 others

CompletedIxabepilone and Vorinostat in Treating Patients With Metastatic Breast CancerRATIONALE: Drugs used in chemotherapy, such as ixabepilone, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing…NCT01084057·Duarte, California and 1 other

TerminatedA Study of Poziotinib in Combination With T-DM1 in HER2-Positive Breast CancerThis is a Phase 1b, open-label, multicenter study to determine the Maximum Tolerated Dose (MTD) or Maximum Administered Dose (MAD) of poziotinib when administered with standard…NCT03429101·Anaheim, California and 1 other

TerminatedLiposomal Bupivacaine in Implant Based Breast ReconstructionObjectives: 1. To evaluate the effect of liposomal bupivacaine on postoperative pain levels.NCT02659501·Loma Linda, California

TerminatedStudy of BMN-673 With Carboplatin and Paclitaxel in Patients With Advanced BRCA-mutated Solid Tumor or Triple Negative Metastatic Breast CancerOpen label, non-randomized, dose escalation and expansion Phase Ia/b trial to evaluate the safety of the combination of BMN 673 and carboplatin, and subsequently BMN 673 in…NCT02358200·San Francisco, California

UnknownMonoclonal Antibody Therapy Plus Cyclosporine and Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Breast CancerRATIONALE: Radiolabeled monoclonal antibodies can locate tumor cells and deliver tumor-killing substances to them without harming normal cells.NCT00003920·Sacramento, California

TerminatedA Pharmacodynamics Pre-surgical Study of LEE011 in Early Breast Cancer Patients (MONALEESA-1)This is a multi-center, open-label Phase II randomized pre-surgical pharmacodynamics study.NCT01919229·Fayetteville, Arkansas and 6 others

PreviousPage 77 of 93Next

Other Conditions in California

Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma